Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults-Reference-Cited by-同舟云学术

Phase I, randomized, observer-blind, placebo-controlled studies to evaluate the safety, reactogenicity and immunogenicity of an investigational non-typeable Haemophilus influenzae (NTHi) protein vaccine in adults

Published:2016-06 Issue:27 Volume:34 Page:3156-3163
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Leroux-Roels Geert,Van Damme Pierre,Haazen Wouter,Shakib Sepehr,Caubet Magalie^ORCID,Aris Emmanuel^ORCID,Devaster Jeanne-Marie,Peeters Mathieu

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Non-typeable Haemophilus influenzae, an under-recognised pathogen;Van Eldere;Lancet Infect Dis,2014

2. Nontypeable Haemophilus influenzae as a pathogen in children;Murphy;Pediatr Infect Dis J,2009

3. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons>or=65 years old;Dworkin;Clin Infect Dis,2007

4. Invasive Haemophilus influenzae disease, Europe, 1996–2006;Ladhani;Emerg Infect Dis,2010

5. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency;Hawdon;Vaccine,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients;Human Vaccines & Immunotherapeutics;2024-04-24

2. Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary Disease;Vaccines;2024-02-18

3. Otitis media: recent advances in otitis media vaccine development and model systems;Frontiers in Microbiology;2024-01-24

4. Naturally-induced serum antibody levels in children to pneumococcal polysaccharide 15B that correlate with protection from nasopharyngeal colonization but anti-serotype 15B antibody has low functional cross-reactivity with serotype 15C;Vaccine;2023-11

5. Real-time PCR has advantages over culture-based methods in identifying major airway bacterial pathogens in chronic obstructive pulmonary disease: Results from three clinical studies in Europe and North America;Frontiers in Microbiology;2023-02-24